Skip to content
10-K

Annual Report

Amphastar Pharmaceuticals, Inc. AMPH

0001297184-26-000009

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 45.37M sh
Shares Diluted FY 2025 · Dec 31, 2025 48.22M sh
Shares Diluted FY 2025 · Dec 31, 2024 52.06M sh
Shares Diluted FY 2025 · Dec 31, 2023 53M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $75.59M
Stock Repurchased FY 2025 · Dec 31, 2024 $85.46M
Stock Repurchased FY 2025 · Dec 31, 2023 $58.14M
Capex FY 2025 · Dec 31, 2025 $34.88M
Capex FY 2025 · Dec 31, 2024 $41.04M
Capex FY 2025 · Dec 31, 2023 $38.17M
Operating Cash Flow FY 2025 · Dec 31, 2025 $156.12M
Operating Cash Flow FY 2025 · Dec 31, 2024 $213.39M
Operating Cash Flow FY 2025 · Dec 31, 2023 $183.5M
Long Term Debt FY 2025 · Dec 31, 2025 $619.71M
Short Term Investments FY 2025 · Dec 31, 2025 $112.64M
Short Term Investments FY 2025 · Dec 31, 2024 $70.04M
Cash And Equivalents FY 2025 · Dec 31, 2025 $170.18M
Cash And Equivalents FY 2025 · Dec 31, 2024 $151.61M
Current Liabilities FY 2025 · Dec 31, 2025 $158.16M
Current Liabilities FY 2025 · Dec 31, 2024 $173.76M
Total Liabilities FY 2025 · Dec 31, 2025 $840.49M
Total Liabilities FY 2025 · Dec 31, 2024 $845.17M
Current Assets FY 2025 · Dec 31, 2025 $636.02M
Current Assets FY 2025 · Dec 31, 2024 $534.07M
Total Assets FY 2025 · Dec 31, 2025 $1.63B
Total Assets FY 2025 · Dec 31, 2024 $1.58B
Eps Diluted FY 2025 · Dec 31, 2025 $2.03
Eps Diluted FY 2025 · Dec 31, 2024 $3.06
Eps Diluted FY 2025 · Dec 31, 2023 $2.60
Eps Basic FY 2025 · Dec 31, 2025 $2.10
Eps Basic FY 2025 · Dec 31, 2024 $3.29
Eps Basic FY 2025 · Dec 31, 2023 $2.85
Sga Expense FY 2025 · Dec 31, 2025 $85.93M
Sga Expense FY 2025 · Dec 31, 2024 $56.72M
Sga Expense FY 2025 · Dec 31, 2023 $51.54M
Rd Expense FY 2025 · Dec 31, 2025 $85.84M
Rd Expense FY 2025 · Dec 31, 2024 $73.91M
Rd Expense FY 2025 · Dec 31, 2023 $73.74M
Net Income FY 2025 · Dec 31, 2025 $98.09M
Net Income FY 2025 · Dec 31, 2024 $159.52M
Net Income FY 2025 · Dec 31, 2023 $137.55M
Operating Income FY 2025 · Dec 31, 2025 $140.4M
Operating Income FY 2025 · Dec 31, 2024 $205.42M
Operating Income FY 2025 · Dec 31, 2023 $196.99M
Gross Profit FY 2025 · Dec 31, 2025 $356.06M
Gross Profit FY 2025 · Dec 31, 2024 $373.86M
Gross Profit FY 2025 · Dec 31, 2023 $351.12M
Cost Of Revenue FY 2025 · Dec 31, 2025 $363.83M
Cost Of Revenue FY 2025 · Dec 31, 2024 $358.11M
Cost Of Revenue FY 2025 · Dec 31, 2023 $293.27M
Revenue FY 2025 · Dec 31, 2025 $719.89M
Revenue FY 2025 · Dec 31, 2024 $731.97M
Revenue FY 2025 · Dec 31, 2023 $644.4M